T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders

Overview

Journal Sci Rep

Specialty Science

Date 2017 Aug 2

PMID 28761062

Citations 23

Authors

Jyoti Rani

Inna Mittal

Atreyi Pramanik

Namita Singh

Namita Dube

Smriti Sharma

Bhanwar Lal Puniya

Muthukurussi Varieth Raghunandanan

Ahmed Mobeen

Srinivasan Ramachandran

Affiliations

Soon will be listed here.

Abstract

We performed integrative analysis of genes associated with type 2 Diabetes Mellitus (T2DM) associated complications by automated text mining with manual curation and also gene expression analysis from Gene Expression Omnibus. They were analysed for pathogenic or protective role, trends, interaction with risk factors, Gene Ontology enrichment and tissue wise differential expression. The database T2DiACoD houses 650 genes, and 34 microRNAs associated with T2DM complications. Seven genes AGER, TNFRSF11B, CRK, PON1, ADIPOQ, CRP and NOS3 are associated with all 5 complications. Several genes are studied in multiple years in all complications with high proportion in cardiovascular (75.8%) and atherosclerosis (51.3%). T2DM Patients' skeletal muscle tissues showed high fold change in differentially expressed genes. Among the differentially expressed genes, VEGFA is associated with several complications of T2DM. A few genes ACE2, ADCYAP1, HDAC4, NCF1, NFE2L2, OSM, SMAD1, TGFB1, BDNF, SYVN1, TXNIP, CD36, CYP2J2, NLRP3 with details of protective role are catalogued. Obesity is clearly a dominant risk factor interacting with the genes of T2DM complications followed by inflammation, diet and stress to variable extents. This information emerging from the integrative approach used in this work could benefit further therapeutic approaches. The T2DiACoD is available at www.http://t2diacod.igib.res.in/ .

Citing Articles

Genetic variants and type 2 diabetes in India: a systematic review and meta-analysis of associated polymorphisms in case-control studies.

Rathod L, Khan S, Mishra S, Das D, Bora K, Shubham S Lancet Reg Health Southeast Asia. 2024; 32:100518.

PMID: 39737336 PMC: 11683328. DOI: 10.1016/j.lansea.2024.100518.

Non parametric differential network analysis: a tool for unveiling specific molecular signatures.

Guzzi P, Roy A, Milano M, Veltri P BMC Bioinformatics. 2024; 25(1):359.

PMID: 39558195 PMC: 11575037. DOI: 10.1186/s12859-024-05969-2.

Understanding complex systems through differential causal networks.

Defilippo A, Giorgi F, Veltri P, Guzzi P Sci Rep. 2024; 14(1):27431.

PMID: 39521851 PMC: 11550418. DOI: 10.1038/s41598-024-78606-w.

The contribution of adiponectin to diabetic retinopathy progression: Association with the AGEs-RAGE pathway.

Fu M, Zhengran L, Yingli L, Tong W, Liyang C, Xi G Heliyon. 2024; 10(17):e36111.

PMID: 39296166 PMC: 11409038. DOI: 10.1016/j.heliyon.2024.e36111.

Network medicine based approach for identifying the type 2 diabetes, osteoarthritis and triple negative breast cancer interactome: Finding the hub of hub genes.

Durrani I, John P, Bhatti A, Khan J Heliyon. 2024; 10(17):e36650.

PMID: 39281650 PMC: 11401126. DOI: 10.1016/j.heliyon.2024.e36650.

References

Schwartz D, Collins F . Medicine. Environmental biology and human disease. Science. 2007; 316(5825):695-6. DOI: 10.1126/science.1141331. View

Dobrowsky R, Rouen S, Yu C . Altered neurotrophism in diabetic neuropathy: spelunking the caves of peripheral nerve. J Pharmacol Exp Ther. 2004; 313(2):485-91. DOI: 10.1124/jpet.104.079921. View

Wu S, Guo Q, Liu G, Zhang J, Zhao C, Ning S . [The relationship of angiotensin I-converting enzyme gene polymorphism with diabetic retinopathy and diabetes myocardial infarction]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004; 21(3):283-5. View

Karolina D, Armugam A, Tavintharan S, Wong M, Lim S, Sum C . MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011; 6(8):e22839. PMC: 3148231. DOI: 10.1371/journal.pone.0022839. View

Strawbridge R, Deleskog A, McLeod O, Folkersen L, Kavousi M, Gertow K . A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia. 2014; 57(6):1159-72. DOI: 10.1007/s00125-014-3215-y. View

Prasad R, Groop L . Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel). 2015; 6(1):87-123. PMC: 4377835. DOI: 10.3390/genes6010087. View

Cameron N, EATON S, Cotter M, Tesfaye S . Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001; 44(11):1973-88. DOI: 10.1007/s001250100001. View

Kyriakou T, Hodgkinson C, Pontefract D, Iyengar S, Howell W, Wong Y . Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 25(2):418-23. DOI: 10.1161/01.ATV.0000149379.72018.20. View

Bang-Berthelsen C, Pedersen L, Floyel T, Hagedorn P, Gylvin T, Pociot F . Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes. BMC Genomics. 2011; 12:97. PMC: 3040732. DOI: 10.1186/1471-2164-12-97. View

10.

Yildirim N, Sahin A, Erol N, Kara S, Uslu S, Topbas S . The relationship between plasma MMP-9 and TIMP-2 levels and intraocular pressure elevation in diabetic patients after intravitreal triamcinolone injection. J Glaucoma. 2008; 17(4):253-6. DOI: 10.1097/IJG.0b013e31815c3a07. View

11.

Li L, Yang G, Ning H, Yang M, Liu H, Chen W . Plasma FGF-21 levels in type 2 diabetic patients with ketosis. Diabetes Res Clin Pract. 2008; 82(2):209-13. DOI: 10.1016/j.diabres.2008.07.012. View

12.

Abu El-Asrar A, Siddiquei M, Nawaz M, Geboes K, Mohammad G . The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes. Mediators Inflamm. 2014; 2014:746415. PMC: 3964896. DOI: 10.1155/2014/746415. View

13.

Muller I, Muller K, Karathanos A, Schonleber H, Rath D, Vogel S . Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease. Atherosclerosis. 2014; 237(2):426-32. DOI: 10.1016/j.atherosclerosis.2014.09.010. View

14.

Raptis A, Viberti G . Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes. 2001; 109 Suppl 2:S424-37. DOI: 10.1055/s-2001-18600. View

15.

Solini A, Santini E, Nannipieri M, Ferrannini E . High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts. Diabetologia. 2006; 49(10):2499-506. DOI: 10.1007/s00125-006-0377-2. View

16.

Zhang Y, Yang L, Gao Y, Fan Z, Cai X, Liu M . MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2. Mol Cell Endocrinol. 2013; 381(1-2):230-40. DOI: 10.1016/j.mce.2013.08.004. View

17.

Zhong H, Beaulaurier J, Lum P, Molony C, Yang X, MacNeil D . Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet. 2010; 6(5):e1000932. PMC: 2865508. DOI: 10.1371/journal.pgen.1000932. View

18.

Latouche C, Natoli A, Reddy-Luthmoodoo M, Heywood S, Armitage J, Kingwell B . MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes. PLoS One. 2016; 11(5):e0155108. PMC: 4862646. DOI: 10.1371/journal.pone.0155108. View

19.

Kin T, Yamada K, Terai G, Okida H, Yoshinari Y, Ono Y . fRNAdb: a platform for mining/annotating functional RNA candidates from non-coding RNA sequences. Nucleic Acids Res. 2006; 35(Database issue):D145-8. PMC: 1669753. DOI: 10.1093/nar/gkl837. View

20.

Negi G, Kumar A, Sharma S . Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J Pineal Res. 2010; 50(2):124-31. DOI: 10.1111/j.1600-079X.2010.00821.x. View